42,863.39
0.01 BRL
8.82 B BRL
104.33 B BRL
About Becton, Dickinson and Company
Sector
Industry
CEO
Thomas E. Polen
Website
Headquarters
Franklin Lakes
Founded
1897
ISIN
BRB1DXBDR008
FIGI
BBG00RD5MPP7
Becton, Dickinson & Co. is a global medical technology company, which engages in the development, manufacture, and sale of medical supplies, devices, laboratory equipment, and diagnostic products. It operates through the following segments: BD Medical, BD Life Sciences, and BD Interventional. The BD Medical segment produces medical technologies and devices that are used to help improve healthcare delivery. The BD Life Sciences segment provides products for the safe collection and transport of diagnostics specimens, instruments, and reagent systems to detect infectious diseases, healthcare-associated infections, and cancers. The BD Interventional segment offers vascular, urology, oncology, and surgical specialty products to hospitals, ambulatory surgery centers, individual healthcare professionals, extended care facilities, alternate site facilities, and patients via its Homecare business. The company was founded by Maxwell W. Becton and Fairleigh S. Dickinson in 1897 and is headquartered in Franklin Lakes, NJ.
Displays a symbol's price movements over previous years to identify recurring trends.
BDX4986709
Becton, Dickinson and Company 3.794% 20-MAY-2050Yield to maturity
6.71%
Maturity date
May 20, 2050
BDX4191433
Becton, Dickinson and Company 4.685% 15-DEC-2044Yield to maturity
6.40%
Maturity date
Dec 15, 2044
BDX4240816
Becton, Dickinson and Company 4.875% 15-MAY-2044Yield to maturity
6.39%
Maturity date
May 15, 2044
BDX4986708
Becton, Dickinson and Company 2.823% 20-MAY-2030Yield to maturity
5.57%
Maturity date
May 20, 2030
Explore more bonds